Exiqon A/S Introduces Serum/Plasma and Cancer microRNA qPCR Arrays  
8/31/2011 10:01:10 AM

VEDBAEK, Denmark, Aug. 31, 2011 (GLOBE NEWSWIRE) -- Exiqon A/S (NASDAQ OMX: EXQ), a leading supplier of high-value gene expression analysis products, today launched two Focus microRNA PCR Panels for sensitive and specific quantification of microRNAs in serum/plasma and in cancer samples.